Meanwhile, Tie2-activating antibody (ABTAA) rescues the phenotype of glaucoma in double Angpt1/Angpt2-deficient mice (Kim et al., 2017), raising the possibility that this signaling pathway could be an interesting therapeutic target for the treatment of glaucoma. Here, ANGPT1 is linked to glaucoma.